Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.570
-0.060 (-3.68%)
Feb 21, 2025, 4:00 PM EST - Market closed
MRKR's stock price has decreased by -62.08% in the past year and price targets may not have had time to catch up.
Marker Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+1,110.19%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $11 → $19 | Strong Buy | Maintains | $11 → $19 | +1,110.19% | Oct 21, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +600.64% | Apr 30, 2024 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades $30 → $10 | Strong Buy → Hold | Downgrades | $30 → $10 | +536.94% | Feb 17, 2022 |
| Piper Sandler | Piper Sandler | Buy Initiates $60 | Buy | Initiates | $60 | +3,721.66% | Mar 25, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +3,721.66% | Mar 19, 2021 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $60 | Buy | Initiates | $60 | +3,721.66% | Mar 18, 2021 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $50 → $25 | Buy → Hold | Downgrades | $50 → $25 | +1,492.36% | May 12, 2020 |
| Piper Sandler | Piper Sandler | Buy Maintains $100 → $60 | Buy | Maintains | $100 → $60 | +3,721.66% | Nov 13, 2019 |
| Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +6,269.43% | May 30, 2019 |